These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 7752341)

  • 1. Solitary renal melanoma? A case with long survival after initial treatment.
    Fujimoto H; Chitose K; Tobisu K; Yamazaki N; Sakamoto M; Kakizoe T
    J Urol; 1995 Jun; 153(6):1887-9. PubMed ID: 7752341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal metastasis of malignant melanoma with unknown primary.
    Shimko MS; Jacobs SC; Phelan MW
    Urology; 2007 Feb; 69(2):384.e9-10. PubMed ID: 17320691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant melanoma of the renal pelvis presenting as a primary tumor.
    Frasier BL; Wachs BH; Watson LR; Tomasulo JP
    J Urol; 1988 Oct; 140(4):812-4. PubMed ID: 3418807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal epithelioid angiomyolipoma with atypia: a series of 40 cases with emphasis on clinicopathologic prognostic indicators of malignancy.
    Brimo F; Robinson B; Guo C; Zhou M; Latour M; Epstein JI
    Am J Surg Pathol; 2010 May; 34(5):715-22. PubMed ID: 20410812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Slow growing flat-type primary malignant melanoma of the esophagus treated with cap-assisted EMR.
    Miyatani H; Yoshida Y; Ushimaru S; Sagihara N; Yamada S
    Dig Endosc; 2009 Oct; 21(4):255-7. PubMed ID: 19961525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous large multivalent immunogen vaccine in patients with metastatic melanoma and renal cell carcinoma.
    Dudek AZ; Mescher MF; Okazaki I; Math VT; Luo X; Curtsinger JM; Miller JS
    Am J Clin Oncol; 2008 Apr; 31(2):173-81. PubMed ID: 18391603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary malignant melanoma of the kidney.
    Bayazit Y; Aridoğan IA; Zeren S; Gönlüşen G; Tansug Z
    Scand J Urol Nephrol; 2002 Feb; 36(1):77-9. PubMed ID: 12002364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged survival in a patient with multiple metachronous tumors.
    Sherriff JM; Walji N
    J Clin Oncol; 2011 Mar; 29(7):e154-5. PubMed ID: 21149650
    [No Abstract]   [Full Text] [Related]  

  • 9. Primary malignant melanoma of the urinary bladder.
    Kojima T; Tanaka T; Yoshimi N; Mori H
    Arch Pathol Lab Med; 1992 Nov; 116(11):1213-6. PubMed ID: 1444751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case report of long-term survival in the patient with anorectal malignant melanoma].
    Yokota K; Takahashi M; Okada K; Ishizu H; Masuko H; Tanaka K; Hata T; Kawamura H; Yamagami H; Watarai H; Tanioka T
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2045-7. PubMed ID: 22202279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of continuous infusion plus pulse interleukin-2 with famotidine in patients with metastatic kidney cancer or melanoma previously treated with interleukin-2.
    Quan WD; Walker PR; Quan FM; Ramirez M; Elsamaloty HM; Ghai V; Vinogradov M; Liles DK
    Cancer Biother Radiopharm; 2006 Oct; 21(5):437-42. PubMed ID: 17105418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative study of HMB-45 monoclonal antibody uptake on various benign and malignant melanocytic lesions].
    Lampert A; Thomine E; Lauret P; Hemet J
    Ann Pathol; 1993; 13(2):100-7. PubMed ID: 8363667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laryngeal primary malignant melanoma: a case report.
    Cojocaru O; Aşchie M; Mocanu L; Bălţătescu GI
    Rom J Morphol Embryol; 2015; 56(4):1513-6. PubMed ID: 26743302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical analysis of primary malignant melanoma of the cervix.
    Ma SQ; Bai CM; Zhong S; Yu XH; Lang JH
    Chin Med Sci J; 2005 Dec; 20(4):257-60. PubMed ID: 16422255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meyerson Phenomenon as a Component of Melanoma in situ.
    Sezer E; Özturk Durmaz E; Çetin E; Şahin S
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):81-2. PubMed ID: 27149137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transition from meningeal melanocytoma to primary cerebral melanoma. Case report.
    Roser F; Nakamura M; Brandis A; Hans V; Vorkapic P; Samii M
    J Neurosurg; 2004 Sep; 101(3):528-31. PubMed ID: 15352613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of renal melanoma metastasis: description of clinico-pathological features.
    Perdonà S; Di Trolio R; Di Lorenzo G; Autorino R
    Arch Ital Urol Androl; 2007 Dec; 79(4):161-3. PubMed ID: 18303733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2 in patients with metastatic malignant melanoma and renal cell carcinoma: a pilot study.
    Goedegebuure PS; Douville LM; Li H; Richmond GC; Schoof DD; Scavone M; Eberlein TJ
    J Clin Oncol; 1995 Aug; 13(8):1939-49. PubMed ID: 7636534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of relapse and response to retreatment in patients with metastatic melanoma or renal cell carcinoma who responded to interleukin-2-based immunotherapy.
    Lee DS; White DE; Hurst R; Rosenberg SA; Yang JC
    Cancer J Sci Am; 1998; 4(2):86-93. PubMed ID: 9532410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanotic Xp11 translocation renal cancer: a case with PSF-TFE3 gene fusion and up-regulation of melanogenetic transcripts.
    Chang IW; Huang HY; Sung MT
    Am J Surg Pathol; 2009 Dec; 33(12):1894-901. PubMed ID: 19809274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.